Introduction Drug discovery is a long, costly, and high-risk process. Developing an innovative drug, from initial research to market launch, typically spans 10 to 15 years, with an average cost of $1Read More…
20Jan/25
26Dec/24
Addressing the Data Challenges in AI-Driven Drug Discovery – Strategies for Progress
Introduction The pharmaceutical industry is facing an unprecedented challenge in drug discovery, with the cost of developing new drugs soaring to an estimated $6.16 billion in 2023—more than double the adjusted costRead More…
02Dec/24
The Role of Artificial Intelligence in Drug Regulation – Applications, Challenges, and Prospects
Introduction The rapid evolution of artificial intelligence (AI) has revolutionized multiple sectors, including the pharmaceutical industry. A review article titled “The Applications and Advances of Artificial Intelligence in Drug Regulation: A GlobalRead More…
05Nov/24
AI’s Triumph in Nobel Prizes: Implications for AI in Drug Development
The 2024 Nobel Prizes brought artificial intelligence (AI) to the forefront, with groundbreaking work recognized in physics and chemistry. On October 8, the Nobel Prize in Physics was awarded to two pioneersRead More…
09Oct/24
Accelerating Drug Development for Rare Diseases with Artificial Intelligence and Machine Learning
Introduction to AI and ML in Rare Disease Research Artificial intelligence (AI) and machine learning (ML) tools, once used primarily for developing structured datasets, have now successfully ventured into the realm ofRead More…
15Sep/24
How AI is Revolutionizing Small Molecule Design in Drug Development
The Game-Changing Role of AI in Small Molecule Design for Drug Development Artificial intelligence (AI) is reshaping the landscape of drug discovery and development, especially in the field of small-molecule design. ThisRead More…
14Aug/24
Artificial Intelligence Revolutionizing Antibody Engineering
Artificial intelligence (AI) is significantly transforming antibody engineering, leading to faster, more efficient, and highly innovative drug discovery processes. Recent advancements in AI technology have shown remarkable progress in designing, optimizing, andRead More…
03Jul/24
Recent Breakthroughs in AI-Enhanced Antibody Discovery
In the fast-paced realm of antibody discovery, artificial intelligence (AI) has emerged as a game-changer, vastly speeding up research and development. The past few months have seen remarkable studies and innovations, underscoringRead More…
12Apr/24
The Dawn of AI-Driven Pharmaceutical Development: Navigating the Future
In the era following the advancement of drug research, artificial intelligence (AI) has emerged as a leading force in pharmaceutical development. In recent years, the pharmaceutical industry has witnessed a significant shiftRead More…
26Mar/24
A Critical Step in AI Drug Development: Molecular Fragmentation
The rise of small molecule drugs discovered through artificial intelligence is a notable trend where computer science and life science converge. Fragment-based drug discovery (FBDD) has emerged as a new approach inRead More…